AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57

Authors: SEGALL MD PAYNE MC ELLIS SW TUCKER GT BOYES RN
Citation: Md. Segall et al., FIRST PRINCIPLES CALCULATION OF THE ACTIVITY OF CYTOCHROME-P450, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 57(4), 1998, pp. 4618-4621

Authors: ROSTAMIHODJEGAN A LENNARD MS WOODS HE TUCKER GT
Citation: A. Rostamihodjegan et al., METAANALYSIS OF STUDIES OF THE CYP2D6 POLYMORPHISM IN RELATION TO LUNG-CANCER AND PARKINSONS-DISEASE, Pharmacogenetics, 8(3), 1998, pp. 227-238

Authors: SEGALL MD PAYNE MC ELLIS W TUCKER GT BOYES N
Citation: Md. Segall et al., EVIDENCE FOR STABILIZATION OF THE LOW-SPIN STATE OF CYTOCHROME-P450 DUE TO SHORTENING OF THE PROXIMAL HEME BOND, Chemical research in toxicology, 11(8), 1998, pp. 962-966

Authors: SIMOOYA OO SIJUMBILA G LENNARD MS TUCKER GT
Citation: Oo. Simooya et al., HALOFANTRINE AND CHLOROQUINE INHIBIT CYP2D6 ACTIVITY IN HEALTHY ZAMBIANS (VOL 45, PG 315, 1998), British journal of clinical pharmacology, 46(4), 1998, pp. 414-414

Authors: SIMOOYA OO SIJUMBIL G LENNARD MS TUCKER GT
Citation: Oo. Simooya et al., HALOFANTRINE AND CHLOROQUINE INHIBIT CYP2D6 ACTIVITY IN HEALTHY ZAMBIANS, British journal of clinical pharmacology, 45(3), 1998, pp. 315-317

Authors: ROSTAMIHODJEGAN A PEACEY SR GEORGE E HELLER SR TUCKER GT
Citation: A. Rostamihodjegan et al., POPULATION-BASED MODELING TO DEMONSTRATE EXTRAPANCREATIC EFFECTS OF TOLBUTAMIDE, American journal of physiology: endocrinology and metabolism, 37(4), 1998, pp. 758-771

Authors: SEGALL MD PAYNE MC ELLIS SW TUCKER GT BOYES RN
Citation: Md. Segall et al., AN AB-INITIO APPROACH TO THE UNDERSTANDING OF CYTOCHROME-P450 LIGAND INTERACTIONS, Xenobiotica, 28(1), 1998, pp. 15-20

Authors: TUCKER GT
Citation: Gt. Tucker, STEREOSELECTIVITY IN DRUG-ACTION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 11-11

Authors: ROSTAMIHODJEGAN A WOLFF K HAY AWM CALVERT R TUCKER GT
Citation: A. Rostamihodjegan et al., POPULATION-KINETICS OF METHADONE IN OPIATE-USERS - CHARACTERIZATION OF TIME-DEPENDENT CHANGES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4726-4726

Authors: GHAHRAMANI P DAVIES SJC YEO WW JACKSON PR TUCKER GT RAMSAY LE
Citation: P. Ghahramani et al., EFFECT OF CYP2D6 GENETIC-POLYMORPHISM ON SIDE-EFFECTS OF AMITRIPTYLINE AND NORTRIPTYLINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51

Authors: SEGALL MD PAYNE MC ELLIS SW TUCKER GT BOYES RN
Citation: Md. Segall et al., AB-INITIO MOLECULAR MODELING IN THE STUDY OF DRUG-METABOLISM, European journal of drug metabolism and pharmacokinetics, 22(4), 1997, pp. 283-289

Authors: WOLFF K ROSTAMIHODJEGAN A SHIRES S HAY AWM FEELY M CALVERT R RAISTRICK D TUCKER GT
Citation: K. Wolff et al., THE PHARMACOKINETICS OF METHADONE IN HEALTHY-SUBJECTS AND OPIATE USERS, British journal of clinical pharmacology, 44(4), 1997, pp. 325-334

Authors: BABER NS TUCKER GT WEBB DJ
Citation: Ns. Baber et al., THE CLINICAL-SECTION OF THE BRITISH-PHARMACOLOGICAL-SOCIETY - PROSPECTS FOR THE FUTURE, British journal of clinical pharmacology, 44(3), 1997, pp. 215-218

Authors: GHAHRAMANI P ELLIS SW LENNARD MS RAMSAY LE TUCKER GT
Citation: P. Ghahramani et al., CYTOCHROMES P450 MEDIATING THE N-DEMETHYLATION OF AMITRIPTYLINE, British journal of clinical pharmacology, 43(2), 1997, pp. 137-144

Authors: BACK DJ MCINNES GT TUCKER GT
Citation: Dj. Back et al., NEW COVER - RENEWED COMMITMENT, British journal of clinical pharmacology, 43(1), 1997, pp. 1-2

Authors: MARSH JCW ELLIS SW CHOWDRY J PARRYJONES N GORDONSMITH EC TUCKER GT
Citation: Jcw. Marsh et al., CYTOCHROMES P45-2D6 AND 2E1 MUTATIONS ARE NOT ASSOCIATED WITH AN INCREASED RISK OF IDIOSYNCRATIC APLASTIC-ANEMIA, Experimental hematology, 25(8), 1997, pp. 608-608

Authors: LIN LY DISTEFANO EW SCHMITZ DA HSU L ELLIS SW LENNARD MS TUCKER GT CHO AK
Citation: Ly. Lin et al., OXIDATION OF METHAMPHETAMINE AND METHYLENEDIOXYMETHAMPHETAMINE BY CYP2D6, Drug metabolism and disposition, 25(9), 1997, pp. 1059-1064

Authors: ROSTAMIHODJEGAN A TUCKER GT
Citation: A. Rostamihodjegan et Gt. Tucker, IS C-MAX AUC USEFUL FOR BIOEQUIVALENCE TESTING/, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1504-1505

Authors: PEACEY SR ROSTAMIHODJEGAN A GEORGE E TUCKER GT HELLER SR
Citation: Sr. Peacey et al., THE USE OF TOLBUTAMIDE-INDUCED HYPOGLYCEMIA TO EXAMINE THE INTRAISLETROLE OF INSULIN IN MEDIATING GLUCAGON-RELEASE IN NORMAL HUMANS, The Journal of clinical endocrinology and metabolism, 82(5), 1997, pp. 1458-1461

Authors: LENNARD MS CREWE HK ELLIS SW TUCKER GT
Citation: Ms. Lennard et al., THE 4-HYDROXYLATION OF TAMOXIFEN BY HUMAN LIVER CYTOCHROMES P450 2D6,2C9 AND 3A4, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 37-37

Authors: CREWE HK ELLIS SW LENNARD MS TUCKER GT
Citation: Hk. Crewe et al., VARIABLE CONTRIBUTION OF CYTOCHROMES P450 2D6, 2C9 AND 3A4 TO THE 4-HYDROXYLATION OF TAMOXIFEN BY HUMAN LIVER-MICROSOMES, Biochemical pharmacology, 53(2), 1997, pp. 171-178

Authors: JENNINGS M SWEETLAND H SMITH CAD WOLF CR LENNARD MS TUCKER GT WOODS HF ROGERS K
Citation: M. Jennings et al., LACK OF RELATIONSHIPS BETWEEN THE DEBRISOQUINE (CYP2D6) AND MEPHENYTION (CYP2C19) OXIDATION POLYMORPHISMS AND SUSCEPTIBILITY TO BREAST-CANCER, Breast, 5(4), 1996, pp. 254-258

Authors: ROSTAMIHODJEGAN A NURMINEN S JACKSON PR TUCKER GT
Citation: A. Rostamihodjegan et al., CAFFEINE URINARY METABOLITE RATIOS AS MARKERS OF ENZYME-ACTIVITY - A THEORETICAL ASSESSMENT, Pharmacogenetics, 6(2), 1996, pp. 121-149

Authors: PEACEY SR GEORGE E ROSTAMIHODJEGAN A BEDFORD C HARRIS N HARDISTY CA TUCKER GT MACDONALD IA HELLER SR
Citation: Sr. Peacey et al., SIMILAR PHYSIOLOGICAL AND SYMPTOMATIC RESPONSES TO SULFONYLUREA AND INSULIN-INDUCED HYPOGLYCEMIA IN NORMAL SUBJECTS, Diabetic medicine, 13(7), 1996, pp. 634-641

Authors: WOLFF K HAY AWM SHIRES S FEELY M CALVERT R ROSTAMIHODJEGAN A TUCKER GT
Citation: K. Wolff et al., SINGLE-DOSE PHARMACOKINETICS OF METHADONE IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 42(5), 1996, pp. 670-670
Risultati: 1-25 | 26-50 | 51-57